Reddy J K, Rao M S
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611.
Mutat Res. 1989 Sep;214(1):63-8. doi: 10.1016/0027-5107(89)90198-x.
Peroxisome proliferators are considered as a novel class of hepatocarcinogenic agents because of their non-mutagenic nature and their ability to cause a significant increase in the levels of hydrogen peroxide generating peroxisomal fatty acid beta-oxidation enzyme system in the liver. Sustained increase in the number of peroxisomes in liver has been shown to induce oxidative stress in the liver. Increased levels of H2O2 generation, hydroxyl free-radical formation, lipid peroxidation and accumulation of lipofuscin are found in the livers of rats following long-term treatment with peroxisome proliferators. Recent evidence indicates the presence of 8-hydroxydeoxyguanosine in the liver DNA of rats chronically treated with a peroxisome proliferator suggesting that this may be the basis for carcinogenesis by this class of non-mutagenic carcinogens.
过氧化物酶体增殖剂被认为是一类新型的致癌剂,因为它们具有非致突变性,并且能够使肝脏中产生过氧化氢的过氧化物酶体脂肪酸β-氧化酶系统的水平显著升高。肝脏中过氧化物酶体数量的持续增加已被证明会在肝脏中诱导氧化应激。长期用过氧化物酶体增殖剂处理的大鼠肝脏中,会出现过氧化氢生成水平升高、羟基自由基形成、脂质过氧化以及脂褐素积累的现象。最近的证据表明,长期用过氧化物酶体增殖剂处理的大鼠肝脏DNA中存在8-羟基脱氧鸟苷,这表明这可能是这类非致突变性致癌物致癌的基础。